GLPBio

NMDA (N-Methyl-D-aspartic acid)

Catalog No.: GC17456Purity:>98.00%Synonyms: NMethylDAspartic Acid
NMDA (N-Methyl-D-aspartic acid) is a specific agonist forNMDA (N-Methyl-D-aspartic acid)receptor mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor.

Products are for research use only. Not for human use. We do not sell to patients.


NMDA (N-Methyl-D-aspartic acid)
Cas No.: 6384-92-5
10mM (in 1mL DMSO)In Stock
$21.00
1
25mgIn Stock
$20.00
1
50mgIn Stock
$33.00
1
100mgIn Stock
$52.00
1
500mgIn Stock
$136.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

NMDA (N-Methyl-D-aspartic acid) is a selective NMDA receptor agonist. NMDA binds to and activates the NMDA receptor to open cation channels, causing Na+ and Ca2+ influx. Overactivation can induce excitotoxicity and neuronal death. NMDA is used in studies related to synaptic plasticity, excitotoxicity, oxidative stress, Alzheimer disease, stroke, and neurodegenerative diseases[1-4].

In vitro, treatment of A549 cells with 300μM NMDA for 1 to 8 hours inhibited Sp1 nuclear protein expression and reduced nuclear translocation[5]. Treatment of RGC-5 cells with 100-800μM NMDA for 48 hours decreased RGC-5 cell viability and induced excitotoxic injury[6]. Treatment of mixed cortical neurons and astrocytes cultures with 12.5μM NMDA for 24 hours induced acute neuronal swelling and extensive necrotic neuronal death[7].

In vivo, a single bilateral intrahippocampal injection of NMDA (12mg/mL; 0.2μL) into Wistar rats damaged neurons in the hippocampal CA1 and CA3 areas, reduced neuronal number, caused glial proliferation, and impaired learning and memory function[8]. A single intravitreal injection of 2μL 30nmol NMDA into C57BL/6 mice and CHOP-deficient mice increased the number of retinal Iba1-positive microglial cells and induced TUNEL-positive apoptotic cells in the retinal ganglion cell layer[9]. After intraperitoneal injection of 4.0g/kg ethanol into Swiss-Webster mice, a single intracerebroventricular injection of 10-500nmol/kg NMDA rapidly and dose-dependently caused loss of righting reflex again[10].

References:

[1] Farber NB. NMDA Antagonists for Treatment-Resistant Depression. Handb Exp Pharmacol. 2019;250:287-305.

[2] Grosjean B, Tsai GE. NMDA neurotransmission as a critical mediator of borderline personality disorder. J Psychiatry Neurosci. 2007 Mar;32(2):103-15.

[3] Low SJ, Roland CL. Review of NMDA antagonist-induced neurotoxicity and implications for clinical development. Int J Clin Pharmacol Ther. 2004 Jan;42(1):1-14.

[4] Kritis AA, Stamoula EG, Paniskaki KA, et al. Researching glutamate-induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci. 2015 Mar 17;9:91.

[5] Li X-H, Fu J-J, Shi X-J, et al. Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis. PLoS ONE. 2023 Aug 9;18(8):e0289530.

[6] Li JH, Yu GS, Wang YD, et al. In vitro protective effect of recombinant prominin-1 combined with microRNA-29b on N-methyl-D-aspartate-induced excitotoxicity in retinal ganglion cells. Int J Ophthalmol. 

[7] Nicole O, Ali C, Docagne F, et al. Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway. J Neurosci. 2001 May 1;21(9):3024-3033.

[8] Fachim HA, Pereira AC, Iyomasa-Pilon MM, et al. Differential Expression of AMPA Subunits Induced by NMDA Intrahippocampal Injection in Rats. Front Neurosci. 2016 Feb 15;10:32.

[9] Sato K, Sato T, Ohno-Oishi M, et al. CHOP deletion and anti-neuroinflammation treatment with hesperidin synergistically attenuate NMDA retinal injury in mice. Exp Eye Res. 2021 Dec;213:108826.

[10] Ferko AP. NMDA enhances the central depressant properties of ethanol in mice. Pharmacol Biochem Behav. 1992;43(1):297-301.

Protocol

Cell experiment [1]:

Cell lines

RGC-5 cells (transformed rat retinal ganglion cell line)

Preparation Method

RGC-5 cells were maintained in RPMI-1640 medium containing 10% fetal bovine serum at 37°C, 5% CO2. RGC-5 cells were treated with NMDA at 100-800μM for 48 hours, followed by MTT assay for cell survival, real-time PCR for VEGF and TGF-β2 mRNA, Western blot for phospho-AKT and phospho-ERK, flow cytometry for apoptosis, and immunofluorescence for VEGF and TGF-β2.

Reaction Conditions

100-800μmol/L; 48h

Applications

NMDA decreased RGC-5 cell survival rate in a concentration-dependent manner with 800μmol/L giving the lowest survival. NMDA induced RGC-5 cell excitotoxicity and apoptosis.
Animal experiment [2]:

Animal models

Male Wistar rats

Preparation Method

Rats were anesthetized with ketamine hydrochloride plus xylazine and received bilateral stereotaxic microinjection of NMDA (0.2μL, 12mg/mL) into the dorsal hippocampus, with post-surgical diazepam and antibiotics; animals were subjected to Morris water maze test at 2 and 4 weeks and perfused for Nissl staining and immunohistochemistry at 24h, 1, 2, and 4 weeks after injection.

Dosage form

0.2μL, 12mg/mL; bilateral intrahippocampal; single injection

Applications

NMDA injection induced loss of neuronal cells and glial proliferation in CA1 and CA3 areas, impaired learning and memory functions in Morris water maze, upregulated GFAP and downregulated NeuN in lesioned CA1 at 1 week, and altered GluR1 and GluR2 expression in CA1, CA3 and hilus over 24h to 4 weeks.

References:

[1] Li JH, Yu GS, Wang YD, et al. In vitro protective effect of recombinant prominin-1 combined with microRNA-29b on N-methyl-D-aspartate-induced excitotoxicity in retinal ganglion cells. Int J Ophthalmol. 2023;16(11):1746-1755.

[2] Fachim HA, Pereira AC, Iyomasa-Pilon MM, et al. Differential Expression of AMPA Subunits Induced by NMDA Intrahippocampal Injection in Rats. Front Neurosci. 2016 Feb 15;10:32.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
6384-92-5
Synonyms
NMethylDAspartic Acid
Chemical Name
(2R)-2-(methylamino)butanedioic acid
SMILES
CNC(CC(=O)O)C(=O)O
Molecular Formula
C5H9NO4
Molecular Weight
147.13
Solubility
DMSO: 5 mg/ml,PBS (pH 7.2): 10 mg/ml
Storage
Store at RT
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for NMDA (N-Methyl-D-aspartic acid)

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%